840
Views
1
CrossRef citations to date
0
Altmetric
Review

Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease

, &
Pages 571-589 | Received 21 Jan 2021, Accepted 17 Mar 2021, Published online: 19 Apr 2021

References

  • Peng X, Xing P, Li X, et al. Towards personalized intervention for Alzheimer’s disease. Genomics Proteomics Bioinf. 2016. 14(5): 289–297.
  • Hampel H, O’Bryant S, Durrleman S, et al. A precision medicine initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modeling. Climacteric. 2017;20(2):107–118.
  • Nikolac Perkovic M, Svob Strac D, Tudor L, et al. Catechol-O-methyltransferase, cognition and Alzheimer’s disease. Curr Alzheimer Res. 2018;15(5):408–419.
  • Nikolac Perkovic M, Pivac N. Genetic markers of Alzheimer’s disease. Adv Exp Med Biol. 2019;1192:27–52.
  • Reitz C. Toward precision medicine in Alzheimer’s disease. Ann Transl Med. 2016;4(6):107.
  • Marešová P, Dolejs J, Mohelska H, et al. Cost of treatment and care for people with Alzheimer’s disease: a meta- analysis. Curr Alzheimer Res. 2019;16(14):1245–1253.
  • Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis. 2020;12:1179573520907397.
  • Knight R, Khondoker M, Magill N, et al. A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia. Dement Geriatr Cogn Disord. 2018;45(3–4):131–151.
  • Glinz D, Gloy VL, Monsch AU, et al. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer’s disease: a meta-analysis. Swiss Med Wkly. 2019;149:w20093.
  • Vancampfort D, Solmi M, Firth J, et al. The impact of pharmacologic and nonpharmacologic interventions to improve physical health outcomes in people with dementia: a meta-review of meta-analyses of randomized controlled trials. J Am Med Dir Assoc. 2020;21(10):1410–1414.e2.
  • Galvin JE. Advancing personalized treatment of Alzheimer’s disease: a call for the N-of-1 trial design. Future Neurol. 2018;13(3):151–160.
  • Abraha I, Rimland JM, Trotta FM, et al. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. BMJ Open. 2017. 7(3): e012759.
  • Sikkes SAM, Tang Y, Jutten RJ, et al. Toward a theory-based specification of nonpharmacological treatments in aging and dementia: focused reviews and methodological recommendations. Alzheimer's Dement. 2020;16. DOI:10.1002/alz.12188.
  • Fuller OK, Whitham M, Mathivanan S, et al. The protective effect of exercise in neurodegenerative diseases: the potential role of extracellular vesicles. Cells. 2020;9(10):2182.
  • Tsai CL, Sun HS, Kuo YM, et al. The role of physical fitness in cognitive-related biomarkers in persons at genetic risk of familial Alzheimer’s disease. J Clin Med. 2019;12(1):1639.
  • Yoneda T, Lewis NA, Knight JE, et al. The importance of engaging in physical activity in older adulthood for transitions between cognitive status categories and death: a coordinated analysis of fourteen longitudinal studies. J Gerontol A Biol Sci Med Sci. 2020:glaa268. DOI:10.1093/gerona/glaa268.
  • De Almeida SIL, Gomes Da Silva M, Marques ASPD. Home-based physical activity programs for people with dementia: systematic review and meta-analysis. Gerontologist. 2020;60(8):600–608.
  • Wang LY, Pei J, Zhan YJ, et al. Overview of meta-analyses of five nonpharmacological interventions for Alzheimer’s disease. Front Aging Neurosci. 2020;12:594432.
  • Zhu L, Li L, Wang L, et al. Physical activity for executive function and activities of daily living in AD patients: a systematic review and meta-analysis. Front Psychol. 2020;11:560461.
  • Colovati MES, Novais IP, Zampol M, et al. Interaction between physical exercise and APOE gene polymorphism on cognitive function in older people. Braz J Med Biol Res. 2021;54(2):e10098.
  • Kurucz A, Bombicz M, Kiss R, et al. Heme oxygenase-1 activity as a correlate to exercise-mediated amelioration of cognitive decline and neuropathological alterations in an aging rat model of dementia. Biomed Res Int. 2018;2018:7212861.
  • Kim D, Cho J, Kang H. Protective effect of exercise training against the progression of Alzheimer’s disease in 3xTg-AD mice. Behav Brain Res. 2019;374:112105.
  • Li B, Liang F, Ding X, et al. Interval and continuous exercise overcome memory deficits related to β-Amyloid accumulation through modulating mitochondrial dynamics. Behav Brain Res. 2019;376:112171.
  • Sarlak Z, Moazzami M, Attarzadeh Hosseini M, et al. The effects of aerobic training before and after the induction of Alzheimer’s disease on ABCA1 and APOE mRNA expression and the level of soluble Aβ1-42 in the hippocampus of male Wistar rats. Iran J Basic Med Sci. 2019;22(4):399–406.
  • Belaya I, Ivanova M, Sorvari A, et al. Astrocyte remodeling in the beneficial effects of long-term voluntary exercise in Alzheimer’s disease. J Neuroinflammation. 2020;17(1):271.
  • Dare LR, Garcia A, Soares CB, et al. The reversal of memory deficits in an Alzheimer’s disease model using physical and cognitive exercise. Front Behav Neurosci. 2020;14:152.
  • Schmidt HL, Carrazoni GS, Garcia A, et al. Strength training or green tea prevent memory deficits in a β-amyloid peptide-mediated Alzheimer’s disease model. Exp Gerontol. 2021;143:111186.
  • Dungan CM, Valentino T, Vechetti IJ Jr, et al. Exercise-mediated alteration of hippocampal Dicer mRNA and miRNAs is associated with lower BACE-1 gene expression and Aβ1-42 in female 3xTg-AD mice. J Neurophysiol. 2020;124(6):1571–1577.
  • Rosa JM, Camargo A, Wolin IAV, et al. Physical exercise prevents amyloid β1-40-induced disturbances in NLRP3 inflammasome pathway in the hippocampus of mice. Metab Brain Dis. 2021;36(2):351–359.
  • Lu LC, Lan SH, Hsieh YP, et al. Horticultural therapy in patients with dementia: a systematic review and meta-analysis. Am J Alzheimers Dis Other Demen. 2020;35:1533317519883498.
  • Falkenheim K, Ruiz-Uribe NE, Haft-Javaherian M, et al. A pilot study investigating the effects of voluntary exercise on capillary stalling and cerebral blood flow in the APP/PS1 mouse model of Alzheimer’s disease. PLoS One. 2020;15(8):e0235691.
  • Cai Z, Liu N, Wang C, et al. Role of RAGE in Alzheimer’s disease. Cell Mol Neurobiol. 2016;36(4):483–495.
  • Stojanovic M, Jin Y, Fagan AM, et al. Physical exercise and longitudinal trajectories in Alzheimer disease biomarkers and cognitive functioning. Alzheimer Dis Assoc Disord. 2020;34(3):212–219.
  • Rabin JS, Klein H, Kirn DR, et al. Associations of physical activity and β-Amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA Neurol. 2019;76(10):1203–1210.
  • Frederiksen KS, Madsen K, Andersen BB, et al. Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer’s disease. Alzheimers Dement. 2019;5(1):208–215.
  • Van Der Kleij LA, Petersen ET, Siebner HR, et al. The effect of physical exercise on cerebral blood flow in Alzheimer’s disease. Neuroimage Clin. 2018;20:650–654.
  • Sobol NA, Hoffmann K, Frederiksen KS, et al. Effect of aerobic exercise on physical performance in patients with Alzheimer’s disease. Alzheimers Dement. 2016;12(12):1207–1215.
  • Hoffmann K, Sobol NA, Frederiksen KS, et al. Moderate-to-high intensity physical exercise in patients with Alzheimer’s disease: a randomized controlled trial. J Alzheimers Dis. 2015;50(2):443–453.
  • Haeger A, Costa AS, Schulz JB, et al. Cerebral changes improved by physical activity during cognitive decline: a systematic review on MRI studies. Neuroimage Clin. 2019;23:101933.
  • Robinson MM, Lowe VJ, Nair KS. Increased brain glucose uptake after 12 weeks of aerobic high-intensity interval training in young and older adults. J Clin Endocrinol Metab. 2018;103(1):221–227.
  • Ward JL, Craig JC, Liu Y, et al. Effect of healthy aging and sex on middle cerebral artery blood velocity dynamics during moderate-intensity exercise. Am J Physiol Heart Circ Physiol. 2018;315(3):H492–H501.
  • Foley KE, Yang HS, Graham LC, et al. Transcriptional profiling predicts running promotes cerebrovascular remodeling in young but not midlife mice. BMC Genomics. 2019;20(1):860.
  • Sisante JV, Vidoni ED, Kirkendoll K, et al. Blunted cerebrovascular response is associated with elevated beta-amyloid. J Cereb Blood Flow Metab. 2019;39(1):89–96.
  • Jia RX, Liang JH, Xu Y, et al. Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis. BMC Geriatr. 2019;19(1):181.
  • Kishita N, Backhouse T, Mioshi E. Nonpharmacological interventions to improve depression, anxiety, and quality of life (QoL) in people with dementia: an overview of systematic reviews. J Geriatr Psychiatry Neurol. 2020;33(1):28–41.
  • Hill NT, Mowszowski L, Naismith SL, et al. Computerized cognitive training in older adults with mild cognitive impairment or dementia: a systematic review and meta-analysis. Am J Psychiatry. 2017;174(4):329–340.
  • Yao S, Liu Y, Zheng X, et al. Do nonpharmacological interventions prevent cognitive decline? A systematic review and meta-analysis. Transl Psychiatry. 2020;10(1):19.
  • Cuevas PEG, Davidson PM, Mejilla JL, et al. Reminiscence therapy for older adults with Alzheimer’s disease: a literature review. Int J Ment Health Nurs. 2020;29(3):364–371.
  • Bentham C, De Marco M, Venneri A. The modulatory effect of cerebrovascular burden in response to cognitive stimulation in healthy ageing and mild cognitive impairment. Neural Plast. 2019;2019:2305318.
  • Behrman S, Chouliaras L, Ebmeier KP. Considering the senses in the diagnosis and management of dementia. Maturitas. 2014;77(4):305–310.
  • Prins AJ, Scherder EJA, Van Straten A, et al. Sensory stimulation for nursing-home residents: systematic review and meta-analysis of its effects on sleep quality and rest-activity rhythm in dementia. Dement Geriatr Cogn Disord. 2020;49(3):219–234.
  • Chang SJ, Lee J, An H, et al. Animal-assisted therapy as an intervention for older adults: a systematic review and meta-analysis to guide evidence-based practice. Worldviews Evid Based Nurs. 2021;18(1):60–67.
  • Peluso S, De Rosa A, De Lucia N, et al. Animal-assisted therapy in elderly patients: evidence and controversies in dementia and psychiatric disorders and future perspectives in other neurological diseases. J Geriatr Psychiatry Neurol. 2018;31(3):149–157.
  • Rodrigo-Claverol M, Malla-Clua B, Marquilles-Bonet C, et al. Animal-assisted therapy improves communication and mobility among institutionalized people with cognitive impairment. Int J Environ Res Public Health. 2020;17(16):5899.
  • Klimova B, Toman J, Kuca K. Effectiveness of the dog therapy for patients with dementia - a systematic review. BMC Psychiatry. 2019;19(1):276.
  • Swall A, Ebbeskog B, Lundh Hagelin C, et al. Stepping out of the shadows of Alzheimer’s disease: a phenomenological hermeneutic study of older people with Alzheimer’s disease caring for a therapy dog. Int J Qual Stud Health Well-being. 2017;12(1):1347013.
  • Wesenberg S, Mueller C, Nestmann F, et al. Effects of an animal-assisted intervention on social behaviour, emotions, and behavioural and psychological symptoms in nursing home residents with dementia. Psychogeriatrics. 2019;19(3):219–227.
  • Smith BC, D’Amico M. Sensory-based interventions for adults with dementia and alzheimer’s disease: a scoping review. Occup Ther Health Care. 2020;34(3):171–201.
  • Margenfeld F, Klocke C, Joos S. Manual massage for persons living with dementia: a systematic review and meta-analysis. Int J Nurs Stud. 2019;96:132–142.
  • Abramowitz L. Working with advanced dementia patients in a day care setting. J Gerontol Soc Work. 2008;50(3–4):25–35.
  • Peck KJ, Girard TA, Russo FA, et al. Music and memory in Alzheimer’s disease and the potential underlying mechanisms. J Alzheimers Dis. 2016;51(4):949–959.
  • Clements-Cortes A, Bartel L. Are we doing more than we know? Possible mechanisms of response to music therapy. Front Med (Lausanne). 2018;5:255.
  • Cocchiara RA, De Lucia F, Koci L, et al. Management of the early stage of Alzheimer’s disease: a systematic review of literature over the past 10 years. Clin Ter. 2020;171(4):e357–e368.
  • Lai X, Wen H, Li Y, et al. The comparative efficacy of multiple interventions for mild cognitive impairment in Alzheimer’s disease: a bayesian network meta-analysis. Front Aging Neurosci. 2020;12:121.
  • Garrido S, Stevens CJ, Chang E, et al. Music and dementia: individual differences in response to personalized playlists. J Alzheimers Dis. 2018;64(3):933–941.
  • Begum MM, Uddin MS, Rithy JF, et al. Analyzing the impact of soft, stimulating and depressing songs on attention among undergraduate students: a cross-sectional pilot study in bangladesh. Front Psychol. 2019;10:161.
  • Paszkiel S, Dobrakowski P, Łysiak A. The impact of different sounds on stress level in the context of EEG, cardiac measures and subjective stress level: a pilot study. Brain Sci. 2020;10(10):728.
  • Harvey AR. Links between the neurobiology of oxytocin and human musicality. Front Hum Neurosci. 2020;14:350.
  • Kanduri C, Raijas P, Ahvenainen M, et al. The effect of listening to music on human transcriptome. PeerJ. 2015;3:e830.
  • Xu A, Zeng Q, Tang Y, et al. Electroacupuncture protects cognition by regulating tau phosphorylation and glucose metabolism via the AKT/GSK3β signaling pathway in Alzheimer’s disease model mice. Front Neurosci. 2020;14:585476.
  • Yu CC, Ma CY, Wang H, et al. Effects of acupuncture on Alzheimer’s disease: evidence from neuroimaging studies. Chin J Integr Med. 2019;25(8):631–640.
  • Zhao FY, Fu QQ, Zheng Z, et al. Verum- versus sham-acupuncture on Alzheimer’s disease (AD) in animal models: a preclinical systematic review and meta-analysis. Biomed Res Int. 2020B;2020:5901573.
  • Wang YY, Yu SF, Xue HY, et al. Effectiveness and safety of acupuncture for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Front Aging Neurosci. 2020;12:98.
  • Song YY, Xu WT, Zhang XC, et al. Mechanisms of electroacupuncture on Alzheimer’s disease: a review of animal studies. Chin J Integr Med. 2020;26(6):473–480.
  • Ghafoor U, Lee JH, Hong KS, et al. Effects of acupuncture therapy on MCI patients using functional near-infrared spectroscopy. Front Aging Neurosci. 2019;11:237.
  • Su XT, Wang LQ, Li JL, et al. Acupuncture therapy for cognitive impairment: a Delphi expert consensus survey. Front Aging Neurosci. 2020;12:596081.
  • Li W, Wang Q, Du S, et al. Acupuncture for mild cognitive impairment in elderly people: systematic review and meta-analyses. Medicine (Baltimore). 2020 Sep 25;99(39):e22365.
  • Zhao Y, Liu Y, Wang Z. Effectiveness of horticultural therapy in people with dementia: a quantitative systematic review. J Clin Nurs. 2020. DOI:10.1111/jocn.15204
  • Roccaro I, Smirni D. Fiat Lux: the light became therapy. An overview on the bright light therapy in Alzheimer’s disease sleep disorders. J Alzheimers Dis. 2020;77(1):113–125.
  • Mitolo M, Tonon C, La Morgia C, et al. Effects of light treatment on sleep, cognition, mood, and behavior in Alzheimer’s disease: a systematic review. Dement Geriatr Cogn Disord. 2018;46(5–6):371–384.
  • Hjetland GJ, Pallesen S, Thun E, et al. Light interventions and sleep, circadian, behavioral, and psychological disturbances in dementia: a systematic review of methods and outcomes. Sleep Med Rev. 2020;52:101310.
  • Wang YQ, Li DM. Advances in art therapy for patients with dementia. Chin Nurs Res. 2016;3(3):105–108.
  • Lorusso LN, Bosch SJ. Impact of multisensory environments on behavior for people with dementia: a systematic literature review. Gerontologist. 2018;58(3):e168–e179.
  • Yu KW, Wang CJ, Wu Y, et al. An enriched environment increases the expression of fibronectin type III domain-containing protein 5 and brain-derived neurotrophic factor in the cerebral cortex of the ischemic mouse brain. Neural Regen Res. 2020;15(9):1671–1677.
  • Juárez-Cedillo T, Gutiérrez-Gutiérrez L, Sánchez-Hurtado LA, et al. Randomized controlled trial of multi-component cognitive stimulation therapy (SADEM) in community-dwelling demented adults. J Alzheimers Dis. 2020;78(3):1033–1045.
  • Jung YH, Lee S, Kim WJ, et al. Effect of integrated cognitive intervention therapy in patients with mild to moderate Alzheimer’s disease. Dement Neurocogn Disord. 2020;19(3):86–95.
  • Masika GM, Yu DSF, Li PWC. Visual art therapy as a treatment option for cognitive decline among older adults. A systematic review and meta-analysis. J Adv Nurs. 2020; Online ahead of print. doi:10.1111/jan.14362.
  • Shigihara Y, Hoshi H, Shinada K, et al. Non-pharmacological treatment changes brain activity in patients with dementia. Sci Rep. 2020;10(1):6744.
  • Wu J, Wang Y, Wang Z. The effectiveness of massage and touch on behavioural and psychological symptoms of dementia: a quantitative systematic review and meta-analysis. J Adv Nurs. 2017;73(10):2283–2295.
  • Goris ED, Ansel KN, Schutte DL. Quantitative systematic review of the effects of non-pharmacological interventions on reducing apathy in persons with dementia. J Adv Nurs. 2016;72(11):2612–2628.
  • Garrido S, Stevens CJ, Chang E, et al. Musical features and affective responses to personalized playlists in people with probable dementia. Am J Alzheimers Dis Other Demen. 2019;34(4):247–253.
  • Huang KY, Liang S, Yu ML, et al. A systematic review and meta-analysis of acupuncture for improving learning and memory ability in animals. BMC Complement Altern Med. 2016;16(1):297.
  • Chung A, Bui L, Mills E. Adverse effects of acupuncture. Which are clinically significant? Can Fam Physician. 2003;49:985–989.
  • Maseda A, Cibeira N, Lorenzo-López L, et al. Multisensory stimulation and individualized music sessions on older adults with severe dementia: effects on mood, behavior, and biomedical parameters. J Alzheimers Dis. 2018;63(4):1415–1425.
  • Sakamoto M, Ando H, Tsutou A. Comparing the effects of different individualized music interventions for elderly individuals with severe dementia. Int Psychogeriatr. 2013;25(5):775–784.
  • Müller P, Achraf A, Zou L, et al. COVID-19, physical (in-)activity, and dementia prevention. Alzheimers Dement (N Y). 2020;6(1):e12091.
  • Menna LF, Santaniello A, Gerardi F, et al. Efficacy of animal-assisted therapy adapted to reality orientation therapy: measurement of salivary cortisol. Psychogeriatrics. 2019;19(5):510–512.
  • Field T. Massage therapy research review. Complement Ther Clin Pract. 2014;20(4):224–229.
  • Tarsha MS, Park S, Tortora S. Body-centered interventions for psychopathological conditions: a review. Front Psychol. 2020;10:2907.
  • King JB, Jones KG, Goldberg E, et al. Increased functional connectivity after listening to favored music in adults with Alzheimer dementia. J Prev Alzheimers Dis. 2019;6(1):56–62.
  • Detweiler MB, Sharma T, Detweiler JG, et al. What is the evidence to support the use of therapeutic gardens for the elderly? Psychiatry Investig. 2012;9(2):100–110.
  • Clark SD, Martin F, McGowan RTS, et al. Physiological state of therapy dogs during animal-assisted activities in an outpatient setting. Animals (Basel). 2020;10(5):819.
  • Clark S, Martin F, McGowan RTS, et al. The impact of a 20-minute animal-assisted activity session on the physiological and emotional states in patients with fibromyalgia. Mayo Clin Proc. 2020A;95(11):2442–2461.
  • Dendaal JS. Animal-assisted therapy – magic or medicine? J Psychosom Res. 2000;49(4):275–280.
  • Ein N, Li L, Vickers K. The effect of pet therapy on the physiological and subjective stress response: a meta-analysis. Stress Health. 2018;34(4):477–489.
  • Lima CR, Martins DF, Reed WR. Physiological responses induced by manual therapy in animal models: a scoping review. Front Neurosci. 2020;14:430.
  • Papadakakis A, Sidiropoulou K, Panagis G. Music exposure attenuates anxiety- and depression-like behaviors and increases hippocampal spine density in male rats. Behav Brain Res. 2019;372:112023.
  • Xing Y, Xia Y, Kendrick K, et al. Mozart, Mozart rhythm and retrograde Mozart Effects: evidences from behaviours and neurobiology bases. Sci Rep. 2016;6(1):18744.
  • Sittler MC, Worschech F, Wilz G, et al. Psychobiological mechanisms underlying the health-beneficial effects of music in people living with dementia: a systematic review of the literature. Physiol Behav. 2021;233:113338.
  • Alain C, Moussard A, Singer J, et al. Music and visual art training modulate brain activity in older adults. Front Neurosci. 2019;13:182.
  • De Pisapia N, Bacci F, Parrott D, et al. Brain networks for visual creativity: a functional connectivity study of planning a visual artwork. Sci Rep. 2016;6(1):39185.
  • King JL, Kaimal G. Approaches to research in art therapy using imaging technologies. Front Hum Neurosci. 2019;13:159.
  • Ng KST, Sia A, Ng MKW, et al. Effects of horticultural therapy on Asian older adults: a randomized controlled trial. Int J Environ Res Public Health. 2018;15(8):1705.
  • Park SA, Son SY, Lee AY, et al. Metabolite profiling revealed that a gardening activity program improves cognitive ability correlated with BDNF levels and serotonin metabolism in the elderly. Int J Environ Res Public Health. 2020;17(2):541.
  • Bilu C, Einat H, Zimmet P, et al. Beneficial effects of daytime high-intensity light exposure on daily rhythms, metabolic state and affect. Sci Rep. 2020;10(1):19782.
  • Kwon SJ, Park J, Park SY, et al. Low-intensity treadmill exercise and/or bright light promote neurogenesis in adult rat brain. Neural Regen Res. 2013;8(10):922–929.
  • Liu Y, Wang L, Pan D, et al. PET evaluation of light-induced modulation of microglial activation and GLP-1R expression in depressive rats. Transl Psychiatry. 2021;11(1):26.
  • Kervezee L, Cuesta M, Cermakian N, et al. The phase-shifting effect of bright light exposure on circadian rhythmicity in the human transcriptome. J Biol Rhythms. 2019;34(1):84–97.
  • Leverse R, Van Someren EJ, Nielen MM, et al. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry. 2011;68(1):61–70.
  • Jung CM, Khalsa SB, Scheer FA, et al. Acute effects of bright light exposure on cortisol levels. J Biol Rhythms. 2010;25(3):208–216.
  • Kohno K, Terao T, Hatano K, et al. Post comparison of [(18) F]-fluorodeoxyglucose uptake in the brain after short-term bright light exposure and no intervention. Acta Psychiatr Scand. 2016;134(1):65–72.
  • Spies M, James GM, Vraka C, et al. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Transl Psychiatry. 2018;8(1):198.
  • Ding N, Jiang J, Xu A, et al. Manual acupuncture regulates behavior and cerebral blood flow in the samp8 mouse model of Alzheimer’s disease. Front Neurosci. 2019;13:37.
  • Su T, Pei L. Acupuncture and oxytocinergic system: the promising treatment for autism. Transl Neurosci. 2021;12(1):96–102.
  • Shen Y, Cheng ZD, Chen YG, et al. Electroacupuncture inhibits atherosclerosis through regulating intestinal flora and host metabolites in rabbit. Evid Based Complement Alternat Med. 2020;2020:5790275.
  • Sun J, Ashley J, Kellawan JM. Can acupuncture treatment of hypertension improve brain health? A mini review. Front Aging Neurosci. 2019;11:240.
  • Tong T, Pei C, Chen J, et al. Efficacy of acupuncture therapy for chemotherapy-related cognitive impairment in breast cancer patients. Med Sci Monit. 2018;24:2919–2927.
  • Okada K, Kurita A, Takase B, et al. Effects of music therapy on autonomic nervous system activity, incidence of heart failure events, and plasma cytokine and catecholamine levels in elderly patients with cerebrovascular disease and dementia. Int Heart J. 2009;50(1):95–110.
  • Chalfont G, Milligan C, Simpson J. A mixed methods systematic review of multimodal nonpharmacological interventions to improve cognition for people with dementia. Dementia. 2020;19(4):1086–1130.
  • De Frutos-lucas J, Frost N, Erickson KI, et al. Does APOE genotype moderate the relationship between PA, brain health and dementia risk? A systematic review. Ageing Res Rev. 2020;64:101173.
  • Kumar A, Singh A, Ekavali. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67(2):195–203.
  • Koynova R, Tenchov B. Natural product formulations for the prevention and treatment of Alzheimer’s disease: a patent review. Recent Pat Drug Deliv Formul. 2018;12(1):23–39.
  • Yusufov M, Weyandt LL, Piryatinsky I. Alzheimer’s disease and diet: a systematic review. Int J Neurosci. 2017;127(2):161–175.
  • Mielech A, Puścion-Jakubik A, Markiewicz-Żukowska R, et al. Vitamins in Alzheimer’s disease-review of the latest reports. Nutrients. 2020. 12(11): 3458.
  • Uddin MS, Kabir MT, Tewari D, et al. Emerging therapeutic promise of ketogenic diet to attenuate neuropathological alterations in Alzheimer’s disease. Mol Neurobiol. 2020;16(1):4961–4977.
  • Wołoszynowska-Fraser MU, Kouchmeshky A, McCaffery P. Vitamin A and retinoic acid in cognition and cognitive disease. Annu Rev Nutr. 2020;40(1):247–272.
  • Zeng J, Chen L, Wang Z, et al. Marginal vitamin A deficiency facilitates Alzheimer’s pathogenesis. Acta Neuropathol. 2017;133(6):967–982.
  • Yuan C, Fondell E, Ascherio A, et al. Long-Term intake of dietary carotenoids is positively associated with late-life subjective cognitive function in a prospective study in us women. J Nutr. 2020;150(7):1871–1879.
  • Ulusu NN, Yilmaz G, Erbayraktar Z, et al. A Turkish 3-center study evaluation of serum folic acid and vitamin B12 levels in Alzheimer disease. Turk J Med Sci. 2015;45(5):1159–1166.
  • Chen H, Liu S, Ji L, et al. Folic acid supplementation mitigates Alzheimer’s disease by reducing inflammation: a randomized controlled trial. Mediators Inflammation. 2016;2016:1–10.
  • Meng H, Li Y, Zhang W, et al. The relationship between cognitive impairment and homocysteine in a B12 and folate deficient population in China. Medicine (Baltimore). 2019;98(47):e17970.
  • Kwok T, Wu Y, Lee J, et al. A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients. Clin Nutr. 2020;39(8):2399–2405.
  • Monacelli F, Acquarone FME, Giannotti C, et al. Vitamin C, aging and Alzheimer’s disease. Nutrients. 2017;9(7):670.
  • Dysken MW, Sano M, Asthana S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease. JAMA. 2014;311(1):33–44.
  • Agarwal P, Holland TM, Wang Y, et al. Association of strawberries and anthocyanidin intake with Alzheimer’s dementia risk. Nutrients. 2019;11(12):3060.
  • Ashley S, Bradburn S, Murgatroyd C. A meta-analysis of peripheral tocopherol levels in age-related cognitive decline and Alzheimer’s disease. Nutr Neurosci. 2019;1–15. DOI:10.1080/1028415X.2019.1681066
  • Dursun E, Gezen-Ak D. Vitamin D basis of Alzheimer’s disease: from genetics to biomarkers. Hormones. 2018;18(1):7–15.
  • Chai B, Gao F, Wu R, et al. Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis. BMC Neurol. 2019;19(1):284.
  • Aguilar-Navarro SG, Mimenza-Alvarado AJ, Jiménez-Castillo GA, et al. Association of vitamin D with mild cognitive impairment and Alzheimer’s dementia in older Mexican adults. Rev Invest Clin. 2019;71(6):381–386.
  • Duchaine CS, Talbot D, Nafti M, et al. Vitamin D status, cognitive decline and incident dementia: the Canadian study of health and aging. Can J Public Health. 2020;111(3):312–321.
  • Tang M, Taghibiglou C. The mechanisms of action of curcumin in Alzheimer’s disease. J Alzheimers Dis. 2017;58(4):1003–1016.
  • Tellone E, Galtieri A, Russo A, et al. Resveratrol: a focus on several neurodegenerative diseases. Oxid Med Cell Longev. 2015;2015:392169.
  • Uddin MS, Hossain MF, Mamun AA, et al. Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration. Sci Total Environ. 2020;725:138313.
  • Kou X, Chen N. Resveratrol as a natural autophagy regulator for prevention and treatment of Alzheimer’s disease. Nutrients. 2017;9(9):927.
  • Turner RS, Thomas RG, Craft S, et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015;85(16):1383–1391.
  • Famenini S, Rigali EA, Olivera-Perez HM, et al. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on omega-3 supplementation. Faseb J. 2017;31(1):148–160.
  • Román GC, Jackson RE, Reis J, et al. Extra-virgin olive oil for potential prevention of Alzheimer disease. Rev Neurol (Paris). 2019;175(10):705–723.
  • Sharma A, Kumar Y. Nature’s derivative(s) as alternative anti-Alzheimer’s disease treatments. J Alzheimers Dis Rep. 2019;3(1):279–297.
  • Yang X, Zheng T, Hong H, et al. Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen-glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model. Front Med. 2018;12(3):307–318.
  • Zhou X, Qi Y, Chen T. Long-term pre-treatment of antioxidant Ginkgo biloba extract EGb-761 attenuates cerebral-ischemia-induced neuronal damage in aged mice. Biomed Pharmacother. 2017;85:256–263.
  • Yang G, Wang Y, Sun J, et al. Ginkgo Biloba for mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials. Curr Top Med Chem. 2016;16(5):520–528.
  • Liu H, Ye M, Guo H. An updated review of randomized clinical trials testing the improvement of cognitive function of Ginkgo biloba extract in healthy people and Alzheimer’s patients. Front Pharmacol. 2020;10:1688.
  • Yuan QJ, Wang CW, Shi J, et al. Effects of Ginkgo biloba on dementia: an overview of systematic reviews. J Ethnopharmacol. 2017;195:1–9.
  • Cassano T, Villani R, Pace L, et al. From cannabis sativa to cannabidiol: promising therapeutic candidate for the treatment of neurodegenerative diseases. Front Pharmacol. 2020;11:124.
  • Uddin MS, Mamun AA, Sumsuzzman DM, et al. Emerging promise of cannabinoids for the management of pain and associated neuropathological alterations in Alzheimer’s disease. Front Pharmacol. 2020;11:1097.
  • Choi JG, Kim N, Huh E, et al. White Ginseng protects mouse hippocampal cells against amyloid-beta oligomer toxicity. Phytother Res. 2017;31(3):497–506.
  • Chang Y, Huang WJ, Tien LT, et al. Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes). Eur J Pharmacol. 2008;578(1):28–36.
  • Qian ZM, Ke Y. Huperzine A: is it an effective disease-modifying drug for Alzheimer’s disease? Front Aging Neurosci. 2014;19(6):216.
  • Oboh G, Ademiluyi AO, Akinyemi AJ. Inhibition of acetylcholinesterase activities and some pro-oxidant induced lipid peroxidation in rat brain by two varieties of ginger (Zingiber officinale). Exp Toxicol Pathol. 2012;64(4):315–319.
  • Khan H, Ullah H, Aschner M, et al. Neuroprotective effects of quercetin in Alzheimer’s disease. Biomolecules. 2019;10(1):59.
  • Shi YC, Pan TM, Liao VH. Monascin from Monascus-fermented products reduces oxidative stress and Amyloid-β toxicity via DAF-16/FOXO in Caenorhabditis elegans. J Agric Food Chem. 2016;64(38):7114–7120.
  • Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008;75(4):787–809.
  • Yanagisawa D, Taguchi H, Yamamoto A, et al. Curcuminoid binds to amyloid-β1-42 oligomer and fibril. J Alzheimers Dis. 2011;24(Suppl 2):33–42.
  • Naoi M, Maruyama W, Shamoto-Nagai M. Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons. J Neural Transm (Vienna). 2018;125(11):1635–1650.
  • Zhang L, Fang Y, Xu Y, et al. Curcumin improves Amyloid β-Peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathway. PLoS One. 2015;10(6):e0131525.
  • Ng TP, Chiam PC, Lee T, et al. Curry consumption and cognitive function in the elderly. Am J Epidemiol. 2006;164(9):898–906.
  • Ihl R, Tribanek M, Bachinskaya N, GOTADAY Study Group. Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer’s disease and vascular dementia: results from a randomised controlled trial. Pharmacopsychiatry. 2012;45(2):41–46.
  • Savaskan E, Mueller H, Hoerr R, et al. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials. Int Psychogeriatr. 2018;30(3):285–293.
  • Cordero JG, García-Escudero R, Avila J, et al. Benefit of Oleuropein Aglycone for Alzheimer’s disease by promoting autophagy. Oxid Med Cell Longev. 2018;2018:5010741.
  • De Nicoló S, Tarani L, Ceccanti M, et al. Effects of olive polyphenols administration on nerve growth factor and brain-derived neurotrophic factor in the mouse brain. Nutrition. 2013;29(4):681–687.
  • Heo JH, Lee ST, Oh MJ, et al. Improvement of cognitive deficit in Alzheimer’s disease patients by long term treatment with Korean red ginseng. J Ginseng Res. 2011;35(4):457–461.
  • Naoi M, Wu Y, Shamoto-Nagai M, et al. Mitochondria in neuroprotection by phytochemicals: bioactive polyphenols modulate mitochondrial apoptosis system, function and structure. Int J Mol Sci. 2019;20(10):2451.
  • Lee CL, Kuo TF, Wang JJ, et al. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid β-infused rat by repressing amyloid β accumulation. J Neurosci Res. 2007;85(14):3171–3182.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.